English
Home > Products > 61622-34-2

China 61622-34-2 Factory

With our exceptional administration, robust technical capability and strict high-quality control procedure, we carry on to provide our consumers with dependable high-quality, reasonable selling prices and superb providers. We aim at becoming amongst your most responsible partners and earning your pleasure for 61622-34-2,CAS NO 61622-34-2,Cefotiam API,Cefotiam, We sincerely welcome mates to negotiate organization and start cooperation. We hope to affix hands with good friends in different industries to produce a fantastic long term.
61622-34-2, Each year, many of our customers would visit our company and achieve great business advancements working with us. We sincerely welcome you to visit us at any time and together we will prevail to a greater success in the hair industry.

Related Products

Hot Products

  • (2R)-4-benzyl-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]morpholin-3-one

    (2R)-4-benzyl-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]morpholin-3-one

    Product Name:(2R)-4-benzyl-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]morpholin-3-one
    Molecular Formula:C21H19F6NO3
    Molecular Weight:447.37
    CAS Registry Number:287930-75-0
  • 6-(Trifluoromethyl)nicotinic acid

    6-(Trifluoromethyl)nicotinic acid

    Product Name:6-(Trifluoromethyl)nicotinic acid
    Molecular Formula:C7H4F3NO2
    Molecular Weight:191.11
    CAS Registry Number:231291-22-8
  • Olaparib

    Olaparib

    Product Name:Olaparib
    Molecular Formula:C24H23FN4O3
    Molecular Weight;434.46
    CAS Registry Number;763113-22-0
  • L-Serine

    L-Serine

    Product Name:L-Serine
    Molecular Formula:C3H7NO3
    Molecular Weight:105.09
    CAS Registry Number:56-45-1
  • 2-Amine Adenosine

    2-Amine Adenosine

    Product Name:2-Amine Adenosine
    Molecular Formula:C10H14N6O4
    Molecular Weight:282.26
    CAS Registry Number:2096/10/8
  • BETA-CYCLODEXTRIN

    BETA-CYCLODEXTRIN

    Product Name:BETA-CYCLODEXTRIN
    Molecular Formula:C42H70O35
    Molecular Weight:1134.99
    CAS Registry Number:7585-39-9
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 61622-34-2

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept